Evvy, a precision-medicine company offering vaginal microbiome testing, AI-powered diagnostics and personalized care for women's health, raised a $40M Series B on September 16, 2026 led by Catalio Capital Management, with Rethink Impact, LabCorp Venture Fund and General Catalyst participating. Founded in 2021, it has now raised $59M total.
Evvy raises $40M Series B for AI-powered women's health diagnostics
Healthtech founders should note continued investor appetite for AI diagnostics tied to a testing and care service, not just software alone.
Source: AlleyWatch
More that helps you.
Inspiren raises $70M Series C to run AI in senior living
Inspiren announced a $70 million Series C on September 10, 2026, with NewView Capital and Insight Partners among the backers. Its platform applies AI to operations inside senior-li…
Graph AI raises $13.3M for pharma safety and adverse-event software
India-based Graph AI raised a $13.3 million post-seed round on September 10, 2026, from Insight Partners and Bessemer. Its software automates pharmaceutical safety and adverse-even…
Arintra raises $25M Series B for autonomous medical coding AI
Arintra raised a $25 million Series B announced the week of Aug 24-26, 2026, led by Define Ventures with Peak XV Partners and Y Combinator, bringing total funding to $51 million. I…
Stockholm's Tandem Health raises $100M Series B for an AI clinical operating system
Tandem Health raised EUR 86.49 million (about $100 million) in a Series B led by the EQT-managed Scaleup Europe Fund, announced September 14, 2026. The startup is expanding from AI…
Get briefs like this tuned to you.
In the app, Founder Briefs are personalized to your country, industry and stage, and you can save the ones that matter.
See plans →